Table 1.
Baseline patient characteristics
| No. (%) | |
|---|---|
| No. of patients | 248 |
| Age (yr) | |
| Median (range) | 63.0 (25–102) |
| ≤ 65 | 134 (54.0) |
| > 65 | 112 (45.2) |
| Not assessed | 2 (0.8) |
| Diagnosis period | |
| 1995–1999 | 17 (6.9) |
| 2000–2004 | 44 (17.7) |
| 2005–2009 | 62 (25) |
| 2010–2014 | 79 (31.9) |
| 2015–2016 | 46 (18.5) |
| Chief complaint | |
| Palpable breast mass | 184 (74.2) |
| Nipple discharge | 10 (4.0) |
| Nipple retraction | 1 (0.4) |
| Breast pain | 7 (2.8) |
| Gynecomastia | 3 (1.2) |
| Axillary mass | 6 (2.4) |
| Chest wall mass | 1 (0.4) |
| Bleeding | 3 (1.2) |
| Skin ulceration | 3 (1.2) |
| Back pain | 3 (1.2) |
| Abnormal physical examination | 3 (1.2) |
| Not assessed | 24 (9.7) |
| Duration of symptom (mo) | |
| Median (range) | 6.0 (0.2–96) |
| Laterality | |
| Unilateral, right | 113 (45.6) |
| Unilateral, left | 115 (46.4) |
| Bilateral | 1 (0.4) |
| Not assessed | 19 (7.7) |
| Multiplicity | |
| No | 203 (81.9) |
| Yes | 12 (4.8) |
| Not assessed | 33 (13.3) |
| ECOG PS | |
| 0 | 81 (32.7) |
| 1 | 115 (46.4) |
| 2 | 5 (2.0) |
| 3 | 2 (0.8) |
| Not assessed | 45 (18.1) |
| Overall TNM stage a) | |
| I | 70 (28.2) |
| II | 101 (40.7) |
| III | 41 (16.5) |
| IV | 19 (7.7) |
| Not assessed | 17 (6.9) |
ECOG PS, Eastern Cooperative Oncology Group performance status.
a)
Based on American Joint Committee on Cancer 7th guideline.